Regavirumab

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Regavirumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
Targetcytomegalovirus glycoprotein B
Clinical data
ATC code
  • none
Identifiers
CAS Number
  • 153101-26-9 ☒N
ChemSpider
  • none
KEGG
 ☒NcheckY (what is this?)  (verify)

Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.[1]

References[edit]

  1. ^ Arizono H, Sugano T, Kaida S, Shibusawa K, Karasawa Y, Esumi Y, et al. (July 1994). "Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys". Arzneimittel-Forschung. 44 (7): 909–13. PMID 7945531.